NASDAQ:CATS - Catasys Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $11.80 -0.16 (-1.34 %) (As of 02/19/2019 07:51 AM ET)Previous Close$11.96Today's Range$11.70 - $12.0252-Week Range$4.03 - $14.29Volume52,080 shsAverage Volume96,635 shsMarket Capitalization$190.45 millionP/E Ratio-13.88Dividend YieldN/ABeta1.82 ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Catasys, Inc. provides big data predictive analytics, artificial intelligence and telehealth, combined with human intervention services to health plans and other third party payors. It offers OnTrak solution to improve treatment outcomes and lower the utilization of medical and behavioral health plan services. The company's OnTrak solution includes medical and psychosocial interventions; and a proprietary Web based clinical information platform and database, psychosocial programs, and integrated care coaching services. Its OnTrak solution combines medical and psychosocial treatments with elements of traditional disease management, case management, and ongoing member support to help organizations treat and manage populations struggling with substance dependence, depression, and anxiety to improve their health and thereby decrease their health care costs. Catasys, Inc.'s OnTrak solution includes various components, such as identification of impactable members, member engagement, enrollment/referral, provider network, outpatient medical treatment, outpatient psychosocial treatment, care coaching, monitoring and reporting, and proprietary Web-based clinical information platform. The company was formerly known as Hythiam, Inc. and changed its name to Catasys, Inc. in March 2011. Catasys, Inc. was founded in 2000 and is based in Los Angeles, California. Receive CATS News and Ratings via Email Sign-up to receive the latest news and ratings for CATS and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Miscellaneous health & allied services, not elsewhere classified Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:CATS Previous SymbolOTCMKTS:CATS CUSIPN/A Webwww.catasys.com Phone310-444-4300Debt Debt-to-Equity RatioN/A Current Ratio0.91 Quick Ratio0.91Price-To-Earnings Trailing P/E Ratio-13.88 Forward P/E Ratio-11.24 P/E GrowthN/A Sales & Book Value Annual Sales$7.72 million Price / Sales24.67 Cash FlowN/A Price / Cash FlowN/A Book Value$0.06 per share Price / Book196.67Profitability EPS (Most Recent Fiscal Year)($0.85) Net Income$-13,600,000.00 Net Margins-122.75% Return on EquityN/A Return on Assets-231.14%Miscellaneous Employees136 Outstanding Shares16,140,000Market Cap$190.45 million OptionableNot Optionable Catasys (NASDAQ:CATS) Frequently Asked Questions What is Catasys' stock symbol? Catasys trades on the NASDAQ under the ticker symbol "CATS." How were Catasys' earnings last quarter? Catasys, Inc. (NASDAQ:CATS) released its earnings results on Wednesday, November, 14th. The company reported ($0.27) earnings per share for the quarter, beating analysts' consensus estimates of ($0.29) by $0.02. The company had revenue of $4.37 million for the quarter, compared to the consensus estimate of $4 million. View Catasys' Earnings History. When is Catasys' next earnings date? Catasys is scheduled to release their next quarterly earnings announcement on Wednesday, March 6th 2019. View Earnings Estimates for Catasys. What price target have analysts set for CATS? 2 Wall Street analysts have issued twelve-month price objectives for Catasys' stock. Their forecasts range from $15.00 to $16.00. On average, they expect Catasys' share price to reach $15.50 in the next twelve months. This suggests a possible upside of 31.4% from the stock's current price. View Analyst Price Targets for Catasys. What is the consensus analysts' recommendation for Catasys? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Catasys in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Catasys. Has Catasys been receiving favorable news coverage? Media stories about CATS stock have trended somewhat positive recently, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Catasys earned a media sentiment score of 1.4 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 6.0 out of 10, meaning that recent press coverage is somewhat likely to have an impact on the company's share price in the next few days. Who are some of Catasys' key competitors? Some companies that are related to Catasys include American Renal Associates (ARA), HemaCare (HEMA), Caladrius Biosciences (CLBS), Pacific Health Care Organization (PFHO), MYnd Analytics (MYND), BioRestorative Therapies (BRTX), American Caresource (GNOW) and Hooper Holmes (HPHW). Who are Catasys' key executives? Catasys' management team includes the folowing people: Mr. Terren S. Peizer, Founder, Chairman & CEO (Age 59)Mr. Richard A. Anderson, Pres & COO (Age 50)Mr. Christopher L. Shirley, Chief Financial Officer (Age 43)Mr. Michael E. Green, Director of Bus. Devel.Mr. Jeremiah Stone, Chief Technology Officer Who are Catasys' major shareholders? Catasys' stock is owned by many different of institutional and retail investors. Top institutional investors include Uniplan Investment Counsel Inc. (1.64%), Janney Montgomery Scott LLC (0.89%), Essex Investment Management Co. LLC (0.60%), Barclays PLC (0.30%), Westwood Management Corp IL (0.25%) and Geode Capital Management LLC (0.18%). Company insiders that own Catasys stock include Michael Edward Sherman, Steve Gorlin and Terren S Peizer. View Institutional Ownership Trends for Catasys. Which institutional investors are selling Catasys stock? CATS stock was sold by a variety of institutional investors in the last quarter, including Weber Alan W, Uniplan Investment Counsel Inc. and Essex Investment Management Co. LLC. View Insider Buying and Selling for Catasys. Which institutional investors are buying Catasys stock? CATS stock was purchased by a variety of institutional investors in the last quarter, including Barclays PLC, Janney Montgomery Scott LLC, Westwood Management Corp IL, Northern Trust Corp and Geode Capital Management LLC. Company insiders that have bought Catasys stock in the last two years include Michael Edward Sherman, Steve Gorlin and Terren S Peizer. View Insider Buying and Selling for Catasys. How do I buy shares of Catasys? Shares of CATS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Catasys' stock price today? One share of CATS stock can currently be purchased for approximately $11.80. How big of a company is Catasys? Catasys has a market capitalization of $190.45 million and generates $7.72 million in revenue each year. The company earns $-13,600,000.00 in net income (profit) each year or ($0.85) on an earnings per share basis. Catasys employs 136 workers across the globe. What is Catasys' official website? The official website for Catasys is http://www.catasys.com. How can I contact Catasys? Catasys' mailing address is 11601 WILSHIRE BOULEVARD SUITE 1100, LOS ANGELES CA, 90025. The company can be reached via phone at 310-444-4300 or via email at [email protected] MarketBeat Community Rating for Catasys (NASDAQ CATS)Community Ranking: 2.6 out of 5 ( )Outperform Votes: 174 (Vote Outperform)Underperform Votes: 158 (Vote Underperform)Total Votes: 332MarketBeat's community ratings are surveys of what our community members think about Catasys and other stocks. Vote "Outperform" if you believe CATS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CATS will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/19/2019 by MarketBeat.com StaffFeatured Article: What is the Rule of 72?